Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ABIRISK

Financiado

Cerrado

Anti Biopharmaceutical Immunization Prediction and analysis of clinical relevanc...

Anti Biopharmaceutical Immunization Prediction and analysis of clinical relevance to minimize the risk The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leader... ver más

28/02/2018

NOVARTIS

33M€

Presupuesto del proyecto: 33M€

Líder del proyecto

NOVARTIS PHARMA AG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 37 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2018-02-28 No tenemos la información de la convocatoria

0% 55% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

37 Participantes

NOVARTIS

0.00€ | Lider

KANTONSSPITAL BASEL

N.D. | Participante

CNRS

N.D. | Participante

FUNDACIO HOSPITAL UNIVERSITA...

N.D. | Participante

Proyectos interesantes

ABIRISK

Medical Technol...

Data Science

33M€ Cerrado

IHIVARNA

Medical Technol...

Data Science

8M€ Cerrado

IMMUNOGENE

Medical Technol...

Data Science

2M€ Cerrado

SAF2015-66193-R

Medical Technol...

Data Science

182K€ Cerrado

VITAL

Medical Technol...

Data Science

12M€ Cerrado

SAF2013-45232-R

Medical Technol...

Data Science

593K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

NOVARTIS PHARMA AG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 33M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recruited per year. This should lead to the constitution of the largest possible cohort in Europe for the study of immunogenicity, a condition critical for the success of the program. ABIRISK will also benefit from the unique expertise of immunologist partners in the development of innovative strategies for predicting the immunogenicity of biopharmaceuticals and for defining its mechanisms. The large number of patients enrolled in the ABIRISK cohorts should make it possible to study the genetic basis of immunogenicity in a new way. We will standardize all clinical and biological information before its integration into a large database for evaluation of the clinical relevance of immunization against biopharmaceuticals and stratification of the risk to patients as a function of factors linked to treatment or to the individual. Computational biology and biostatistical modeling will be used to develop models for predicting immunogenicity that will be validated with the ABIRISK database. The complementarity between the clinical partners from different disciplines, immunologists, methodologists and biostatisticians will create a unique task force for studies of biopharmaceutical immunogenicity. The direct outcomes of the proposed work will be greater understanding of the mechanisms involved in the emergence of anti-drug antibodies, the development of new methods for predicting immunogenicity and a comprehensive view of the respective value of predictive tools, and guidelines for the development of new biopharmaceuticals and patient care.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores